CELL SOURCE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0008 USD | +300.00% |
|
-.--% | -99.83% |
| 03-22 | Cell Source, Inc. announced that it has received $4.76017 million in funding | CI |
| 2023 | Cell Source, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CELL SOURCE, INC. | Bio Therapeutic Drugs | +300.00% | -.--% | -99.83% | +100.00% | -99.89% | 32.82K | - | - | - |
- Stock Market
- Equities
- CLCS Stock
- Charts Cell Source, Inc.
- Relative Strength Chart
